Researchers from the University of North Carolina have discovered that they can potentially improve cancer immunotherapy drugs by binding 2 compounds to a single nanoparticle. The team’s work was presented this week at the annual meeting of the American Association for Cancer Research.
“Our data shows that 2 compounds on a single nanoparticle will make immunotherapy treatments even more effective,” senior author Dr. Andrew Wang said in prepared remarks.
Get the full story at our sister site, Drug Delivery Business News.